Trademarkia Logo

Canada

C$
BAYSHORE EXPRESS
SEARCHED

on 9 Aug 2024

Last Applicant/ Owned by

POLAR VALLEY INVESTMENTS LTD. A LEGAL ENTITY

2101 Hadwen RoadMississauga

ONTARIO

CA

L5K2L3

Serial Number

2016401 filed on 9th Mar 2020

Correspondent Address

RICHES, MCKENZIE & HERBERT LLP

SUITE 18002 BLOOR STREET EASTTORONTO

ONTARIO

CA

M4W3J5

BAYSHORE EXPRESS

Trademark usage description

antiarrhythmic drugs; antiepileptic drugs; antipyretic drugs with sedative effect; antituberculous drugs; antitumor drugs; antitumour drugs; drug deli Read More

Classification Information


Class [005]
Antiarrhythmic drugs; antiepileptic drugs; antipyretic drugs with sedative effect; antituberculous drugs; antitumor drugs; antitumour drugs; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; inhaled pharmaceutical preparations for treating respiratory diseases and disorders; pharmaceutical antiallergic preparations and substances; pharmaceutical anti-allergic preparations and substances; pharmaceutical antitussive-cold preparations; pharmaceutical cold preparations; pharmaceutical cough preparations; pharmaceutical hormonal preparations, namely, corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for hydrating the skin during pregnancy; pharmaceutical preparations for inducing erections; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for preventing skin blemishes during pregnancy; pharmaceutical preparations for reducing cholesterol; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for suppressing tumours; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the prevention of stretch marks; pharmaceutical preparations for the relief of insect bites; pharmaceutical preparations for the relief of pain; pharmaceutical preparations for the treatment of acne; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for the treatment of asthma; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceutical preparations for the treatment of blood disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for the treatment of bone fractures; pharmaceutical preparations for the treatment of brain diseases and disorders, namely, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, multiple sclerosis; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of carpal tunnel syndrome; pharmaceutical preparations for the treatment of chronic pain; pharmaceutical preparations for the treatment of cranial or facial nerve disorders; pharmaceutical preparations for the treatment of dandruff; pharmaceutical preparations for the treatment of degenerative nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis; pharmaceutical preparations for the treatment of dental and oral diseases; pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders; pharmaceutical preparations for the treatment of diseases, disorders and infections of the spinal cord systems and related cartilage and tissue; pharmaceutical preparations for the treatment of drug and alcohol abuse; pharmaceutical preparations for the treatment of epilepsy; pharmaceutical preparations for the treatment of erectile dysfunction; pharmaceutical preparations for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical preparations for the treatment of genito-urinary and pelvic diseases, disorders and infections, namely infertility, sexually transmitted diseases, incontinence and sexual dysfunction; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of glaucoma; pharmaceutical preparations for the treatment of gout; pharmaceutical preparations for the treatment of headaches; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for the treatment of hypercholesterolemia; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the treatment of infectious diseases, namely respiratory infections, eye infections; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; pharmaceutical preparations for the treatment of inflammatory muscle diseases and disorders; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia; pharmaceutical preparations for the treatment of metabolic disorders, namely diabetes, bulimia nervosa, anorexia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of migraine; pharmaceutical preparations for the treatment of motion sickness; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of myalgia and neuralgia; pharmaceutical preparations for the treatment of neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy; pharmaceutical preparations for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders; pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, myasthenia gravis, Huntington's disease; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the treatment of Parkinson's disease; pharmaceutical preparations for the treatment of physical and psychological addictions, namely, gambling addiction, eating disorders and addictions, nicotine addiction, Internet addiction, drug addiction; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders; pharmaceutical preparations for the treatment of respiratory diseases, disorders and infections; pharmaceutical preparations for the treatment of skin irritations, namely bee stings, sunburn, rashes, sores, corns, calluses, and acne; pharmaceutical preparations for the treatment of smoking cessation; pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease; pharmaceutical preparations for the treatment of the diseases, disorders and infections of the central nervous system namely brain, movement, ocular motility and spinal cord diseases; pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of varicose veins; pharmaceutical preparations for the treatment of vascular diseases; pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical preparations for treating allergic rhinitis; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating asthma; pharmaceutical preparations for treating chloasma; pharmaceutical preparations for treating dandruff; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating dry skin caused by pregnancy; pharmaceutical preparations for treating gastrointestinal disorders; pharmaceutical preparations for treating halitosis; pharmaceutical preparations for treating heatstroke; pharmaceutical preparations for treating hypoglycaemia; pharmaceutical preparations for treating hypoglycemia; pharmaceutical preparations for treating malignant tumours; pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for treating sunburn; pharmaceutical preparations for treating the symptoms of radiation sickness; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in discouraging the smoking habit; pharmaceutical preparations for use in gastroenterology; ; pharmaceutical preparations for use in ocular disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for wounds; pharmaceutical products and preparations against dry skin caused by pregnancy; pharmaceutical products and preparations for hydrating the skin during pregnancy; pharmaceutical products for ophthalmological use; pharmaceutical products for the treatment of cancer; pharmaceutical products for treating respiratory diseases; radioactive pharmaceutical preparations for in vivo diagnostic or therapeutic use; radioactive pharmaceutical preparations for in vivo diagnostics or therapeutic use; sunburn preparations for pharmaceutical purposes


Classification kind code

11

Class [016]
Catalogues; mailing labels; pharmaceutical information leaflets


Classification kind code

11

Class [035]
Administration of customer loyalty programs; advice and information about customer services and product management and prices on Internet sites in connection with purchases made over the Internet; providing administrative assistance to pharmacies for managing drug inventories; retail services for pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale services for pharmaceutical, veterinary and sanitary preparations and medical supplies


Classification kind code

11

Class [036]
Assisting those in need of financial support from government programs namely in obtaining such financial support in the fields of prescription drugs, home and community care services, medical devices and home renovation grants; bill payment services; bill payment services provided through a web site; bill payment services provided through a website; providing non-credit based financial assistance for the purchase of diabetes supplies namely diabetes pharmaceuticals and diabetes medical devices


Classification kind code

11

Class [039]
Air freight shipping services; delivery of goods by air; delivery of goods by mail order; delivery of goods by train; delivery of goods by truck; parcel delivery; parcel shipping services


Classification kind code

11

Class [042]
Pharmaceutical product evaluation


Classification kind code

11

Class [044]
Dispensing of pharmaceuticals; drugstore dispensary services; medical and pharmaceutical services namely: providing intravenous infusion services in the home, hospitals or in clinical environments; medicinal pharmaceutical services; pharmaceutical consultancy services; pharmaceutical services; pharmacists' services to make up prescriptions; pharmacy advice; pharmacy dispensary services; pharmacy services; preparation of prescriptions by pharmacists; preparation of prescriptions in pharmacies


Classification kind code

11

Class [045]
Personal shopping for others


Classification kind code

11

Mark Details


Serial Number

2016401

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 22
on 9th Aug 2024
Search Recorded
Submitted for opposition 20
on 9th Aug 2024
Examiner's First Report
Submitted for opposition 287
on 8th Jun 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 9th Mar 2020
Filed
Submitted for opposition 1
on 9th Mar 2020
Created
Submitted for opposition 31
on 9th Mar 2020
Formalized